πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 635 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9873685

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9873692

Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9873696

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9872855

(2R,4R)-5-(5β€²-Chloro-2β€²-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amin

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9868698

(2S,4R)-5-(5β€²-chloro-2β€²-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methy

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9845332

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9839639

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9840460

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9828367

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9783507

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9771337

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9771350

Diamide compounds having muscarinic receptor antagonist and Ξ²2 adrenergic receptor agonist

Theravance Respiratory Company, LLC Β· Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9765028

Crystalline freebase forms of a biphenyl compound

Theravance Biopharma R&D IP, LLC Β· Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9725448

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9725470

Substituted naphthyridines as JAK kinase inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9724359

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9688692

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9688616

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9682957

Diamide compounds having muscarinic receptor antagonist and Ξ²2 adrenergic receptor agonis

Theravance Respiratory Company, LLC Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9682052

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9683002

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9675599

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9669027

Hepatitis C virus inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9670140

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted